[Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study]. 1977

L Gram, and K Wulff, and K E Rasmussen, and H Flachs, and A Würtz-Jørgensen, and K W Sommerbeck, and V Løhren

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L Gram, and K Wulff, and K E Rasmussen, and H Flachs, and A Würtz-Jørgensen, and K W Sommerbeck, and V Løhren
November 1975, Epilepsia,
L Gram, and K Wulff, and K E Rasmussen, and H Flachs, and A Würtz-Jørgensen, and K W Sommerbeck, and V Løhren
January 1974, Proceedings of the Australian Association of Neurologists,
L Gram, and K Wulff, and K E Rasmussen, and H Flachs, and A Würtz-Jørgensen, and K W Sommerbeck, and V Løhren
April 1979, Ugeskrift for laeger,
L Gram, and K Wulff, and K E Rasmussen, and H Flachs, and A Würtz-Jørgensen, and K W Sommerbeck, and V Løhren
October 1978, Journal of chromatography,
L Gram, and K Wulff, and K E Rasmussen, and H Flachs, and A Würtz-Jørgensen, and K W Sommerbeck, and V Løhren
February 1975, Psychiatrie, Neurologie, und medizinische Psychologie,
L Gram, and K Wulff, and K E Rasmussen, and H Flachs, and A Würtz-Jørgensen, and K W Sommerbeck, and V Løhren
March 1980, Il Farmaco; edizione pratica,
L Gram, and K Wulff, and K E Rasmussen, and H Flachs, and A Würtz-Jørgensen, and K W Sommerbeck, and V Løhren
December 1972, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
L Gram, and K Wulff, and K E Rasmussen, and H Flachs, and A Würtz-Jørgensen, and K W Sommerbeck, and V Løhren
February 1975, European journal of clinical pharmacology,
L Gram, and K Wulff, and K E Rasmussen, and H Flachs, and A Würtz-Jørgensen, and K W Sommerbeck, and V Løhren
September 1978, Minerva pediatrica,
L Gram, and K Wulff, and K E Rasmussen, and H Flachs, and A Würtz-Jørgensen, and K W Sommerbeck, and V Løhren
July 1979, Brain research,
Copied contents to your clipboard!